Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30673227 | 0.85 | GAA (0.43) | GAAL3MBTL1EPHX1IDO1LMNA | |
| SCHEMBL12759079 | 0.75 | EPHX2 (0.38) | LMNAALDH1A1MCOLN3CYP2C19CHRM3 | |
| Biphenyl SCHEMBL27916362 | 0.73 | ROCK2 (0.37) | GAAL3MBTL1EPHX1LMNAALDH1A1 | |
| SCHEMBL12759095 | 0.73 | SIGMAR1 (0.42) | CYP2D6 | |
| SCHEMBL20712624 | 0.71 | SLC6A4 (0.42) | GAAL3MBTL1EPHX1IDO1LMNA | |
| SCHEMBL4603729 | 0.69 | GAA (0.55) | GAAL3MBTL1EPHX1IDO1LMNA | |
| SCHEMBL29054020 | 0.69 | GAA (0.55) | GAAL3MBTL1EPHX1IDO1LMNA | |
| SCHEMBL27821886 | 0.69 | GAA (0.55) | GAAL3MBTL1EPHX1IDO1LMNA | |
| SCHEMBL5185625 | 0.69 | TSHR (0.54) | GAAL3MBTL1EPHX1IDO1LMNA | |
| SCHEMBL27514711 | 0.69 | TSHR (0.54) | GAAL3MBTL1EPHX1IDO1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8466306-B2 | Sulfonated organophosphine compounds and use in hydroformylation processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-8466306-B2 | Sulfonated organophosphine compounds and use in hydroformylation processes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-06-18 | — | — | US | disclosed |
| US-20110054203-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-03-03 | — | — | US | disclosed |
| US-20110054203-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2011-03-03 | — | — | US | disclosed |
| WO-2009091669-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-07-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110054203-A1 | SULFONATED ORGANOPHOSPHINE COMPOUNDS AND USE IN HYDROFORMYLATION PROCESSES | ORMDL3, IP6K3, ALK | GAA 3692/4885L3MBTL1 2290/4885EPHX1 1809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.